How should a 31-year-old man with involuntary leg movements at rest and random pauses in activities such as showering or dressing be evaluated and managed?

Evaluation and Management of Suspected Restless Legs Syndrome

This 31-year-old man's symptoms—involuntary leg movements at rest and random pauses during activities—require immediate evaluation for Restless Legs Syndrome (RLS), though the "random pauses" are atypical and warrant broader neurological assessment.

Diagnostic Approach

First, confirm RLS diagnosis using the five essential criteria 1:

1. Urge to move legs with or without uncomfortable sensations
2. Symptoms begin or worsen at rest (lying down, sitting)
3. Relief with movement (walking, stretching) that lasts during activity
4. Worse in evening/night than daytime
5. Not explained by another condition (leg cramps, venous stasis, arthritis, positional discomfort, habitual foot tapping)

Critical caveat: The "random pauses during tasks" described do NOT fit classic RLS and suggest possible attention deficit, executive dysfunction, or other neurological conditions requiring separate evaluation. RLS causes an urge to move, not task interruption or cognitive pauses.

Initial Workup

Obtain morning iron studies (avoiding iron supplements/foods for 24 hours prior) 2:

• Serum ferritin
• Transferrin saturation
• Total iron binding capacity

Screen for exacerbating factors 2:

• Alcohol and caffeine use
• Medications: antihistamines, serotonergic agents (SSRIs, SNRIs), antidopaminergics (metoclopramide, prochlorperazine)
• Untreated obstructive sleep apnea
• Renal insufficiency
• Pregnancy status (though unlikely in male patient)

Treatment Algorithm

Step 1: Address Iron Deficiency

Iron supplementation is indicated if 2:

• Ferritin ≤75 ng/mL OR transferrin saturation <20%: Use oral or IV iron
• Ferritin 75-100 ng/mL: Use IV iron only

This differs from general population guidelines and should be implemented before or alongside other therapies.

Step 2: First-Line Pharmacotherapy

The 2025 AASM guidelines establish clear first-line agents 2:

Strongest recommendations (all strong, moderate certainty):

• Gabapentin enacarbil (preferred formulation)
• Gabapentin
• Pregabalin
• IV ferric carboxymaltose (if appropriate iron parameters)

These alpha-2-delta ligands are now preferred over dopamine agonists due to lower risk of augmentation—a devastating complication where symptoms worsen, occur earlier in the day, and spread to arms/trunk 3, 4.

Step 3: Alternative Therapies

If alpha-2-delta ligands fail or are contraindicated 2:

• Extended-release oxycodone or other opioids (conditional recommendation)
• Dopamine agonists (pramipexole, ropinirole, rotigotine): Now conditionally recommended AGAINST for standard use due to augmentation risk, but may be used short-term in select patients who prioritize immediate symptom relief over long-term safety

Avoid routinely 2:

• Levodopa (high augmentation risk)
• Bupropion
• Carbamazepine

Key Clinical Pitfalls

Augmentation recognition: Watch for symptoms occurring earlier in the day, increased intensity, or spread beyond legs. This requires switching from dopamine agonists to alpha-2-delta ligands or opioids 3, 4.

Misdiagnosis risk: Without proper differential diagnosis, 16% of patients without RLS may be misclassified 1. The "random pauses" in this patient's presentation are NOT consistent with RLS and require investigation for:

• ADHD or executive dysfunction
• Absence seizures
• Obsessive-compulsive behaviors
• Other movement disorders

Iron monitoring: Recheck iron studies if symptoms worsen, especially when considering augmentation 3.

Addressing the Atypical Features

The described "pauses to do something random before completing tasks" requires separate neurological evaluation, potentially including:

• Detailed cognitive/executive function assessment
• EEG if seizure activity suspected
• Psychiatric evaluation for attention or compulsive disorders

These pauses are not explained by RLS pathophysiology, which involves sensorimotor discomfort relieved by movement, not task interruption or behavioral fragmentation 1, 5.